About this trial
This is an open label multi-center study with the aim of evaluating the efficacy of adipose tissue processed with the SyntrFuge™ system in facial aesthetics and contouring. Patients will be enrolled to the treatment group with adipose tissue processed with the SyntrFuge™ system followed by an injection of autologous microsized adipose tissue in the treatment sites.
Eligibility criteria
Qualifiers
Subjects aged of 18-70 years old
Willing and able to read and sign the informed consent and other study materials
Written informed consent has been obtained prior to any study-related procedures
Subjects are ambulatory
Disqualifiers
Subjects without decisional capacity
Subjects unable to give informed, written consent
Subjects with active infection (redness, swelling, pain, suppuration)
Subjects with any uncontrolled systemic disease
Trial design
Treatments tested in this trial
- SyntrFuge System